The undefined relationship between tumor antigens and histocompatibility antigens on cancer cells

Albright A. L., Gill T. J. III,Geyer S. J.: Immunogenic control of brain tumor growth in rats- Cancer Res.37, 2512, 1977. Baldwin R. W.: Immunological aspects of chemical carcinogenesis - Advanc. Cancer Res.18, 1, 1973. Basombrio M. A.: Search for common antigenicities among twenty-five sarcomas induced by methylcholanthrene - Cancer Res.30, 2058, 1970. Bear R. H., Jr.,Roholt O. A., Pressman D.: Protection against syngeneic tumor grafts induced by inoculation with normal allogeneic tissues - Immunol. Commun.6, 547, 1977. Blank K. J., Lilly F.: Evidence for an H-2/viral protein complex on the cell surface as the basis for the H-2 restriction of cytotoxicity - Nature (Lond.)269, 808, 1977. Bodmer W. F.: A new genetic model for allelism at histocompatibility loci: polymorphism for control of gene expression -Transplant. Proc.5, 1471, 1973. Bowen J. G., Baldwin R. W.: Tumour-specific antigen related to rat histocompatibility antigens - Nature (Lond.)258, 15, 1975. Bowen J. G., Baldwin R. W.: Tumour antigens and alloantigens. II. Lack of association of rat hepatoma-D23-specific antigen with β20-microglobulin - Int. J. Cancer23, 833, 1979. Burton R. C., Chism S. E., Warner N. L.:In vitro induction of tumor-specific immunity. III. Lack of requirement for H-2 compatibility in lysis of tumor targets by T cells activatedin vitro to oncofetal and plasmocytoma antigens - J. Immunol.118, 971, 1977. Callahan G. N., Allison J. P., Pellegrino M. A., Reisfeld R. A.: Physical association of histocompatibility antigens and tumor-associated antigens on the surface of murine lymphoma cells - J. Immunol.122, 70, 1979. Carbone G., Invernizzi G., Meschini A., Parmiani G.:In vitro andin vivo expression of original and foreign H-2 antigens and of the tumor-associated transplantation antigen of a murine fibrosarcoma - Int. J. Cancer21, 85, 1978. Chauvenet P. H., Smith R. T.: Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation ofin vitro alloantigen expression andin vivo alloimmunity from tumor-specific transplantation antigen strength -Int. J. Cancer22, 79, 1978. Cikes M., Friberg S., Jr.,Klein G.: Progressive loss of H-2 antigens with concomitant increase of cell-surface antigen(s) determined by Moloney leukemia virus in cultured murine lymphomas - J. nat. Cancer Inst.50, 347, 1973. Collavo D., Parenti A., Biasi G., Chieco-Bianchi L., Colombatti A.: Secondaryin vitro generation of cytolytic T-lymphocytes (CTL’s) in the murine sarcoma virus system. Virusspecific CTL induction across the H-2 barriers - J. nat. Cancer Inst.61, 885, 1978. Demant P.: H-2 gene complex and its role in alloimmune reactions - Transplant. Rev.15, 162, 1973. De Vries J. E., Cornain S., Rumke P.: Cytotoxicity of non-T versus T-lymphocytes from melanoma patients and healthy donors on shortand long-term cultured melanoma cells - Int. J. Cancer14, 427, 1974. Doherty P. C., Zinkernagel R. M.: H-2 compatibility is required for T-cell-mediated lysis of target cells infected with lymphocyte choriomeningitis virus - J. exp. Med.141, 502, 1975. Fenyo E. M., Yefenof E., Klein E., Klein G.: Immunization of mice with syngeneic Moloney lymphoma cells induces antibodies against virion envelope glycoprotein and virusinduced cell surface antigens - J. exp. Med.146, 1521, 1977. Forni G., Giovarelli M., Negro-Ponzi A., Landolfo S.: H-2 restriction and Ia-dependence of the efficient immune recognition of minor histocompatibility antigensin vivo - Immunogenetics9, 199, 1979. Fossati G., Holden H. T., Herberman R. B.: Evaluation of the cell-mediated immune response to murine sarcoma virus by (125I) iododeoxyuridine assay and comparison with chromium 51 and microcytotoxicity assays - Cancer Res.35, 2600, 1975. Fujimoto S., Chen C. H., Sabbadini E., Sehon A. H.: Association of tumor and histocompatibility antigens in sera of lymphoma-bearing mice - J. Immunol,111, 1093, 1973. Fujiwara H., Aoki H., Tsuchida T., Hamaoka T.: Immunologic characterization of tumorassociated transplantation antigens on MM102 mammary tumor eliciting preferentially helper T cell activity - J. Immunol.121, 1591, 1978. Garrido F., Festenstein H., Schirrmacher V.: Further evidence for derepression of H-2 and Ia-like specificities of foreign haplotypes in mouse tumour cell lines - Nature (Lond.)261, 271, 1976. Garrido F., Perez M., Torres M. D.: Absence of four H-2d antigenic specificities in an H-2d sarcoma - J. Immunogenet.6, 83, 1979. Germain R. W., Dorf H. E., Benacerraf B.: Inhibition of T lymphocyte-mediated tumorspecific lysis by alloantisera directed against the H-2 serological specificities of the tumor - J. exp. Med.142, 1023, 1975. Gipson T. G., Imamura M., Conliffe M. D., Martin W. J.: Lung tumor-associated derepressed alloantigen coded for by the K region of the H-2 major histocompatibility complex - J. exp. Med.147, 1363, 1978. Gomard E., Duprez V., Henin Y., Levy J. P.: H-2 region product determinant in immune cytolysis of syngeneic tumour cells by anti-MSV T lymphocytes - Nature (Lond.)250, 707, 1976. Haywood G. R., McKahn C. F.: Antigenic specificities on murine sarcoma cells. Reciprocal relationship between normal transplantation antigens (H-2) and tumor-specific immunogenicity - J. exp. Med.133, 1171, 1971. Herberman R. B.: Existence of tumor immunity in man - In:Cohen S., Green I. (Eds): Mechanisms of tumor immunity. J. Wiley and sons, New York, 1977; p. 175. Hewitt H. B.: A critical examination of the foundations of immunotherapy for cancer - Clin. Radiol.30, 361, 1979. Holden H. T., Landolfo S., Herberman R. B.: T-cell dependent reactivity against tumorassociated antigens on allogeneic target cells - Transplant. Proc.9, 1149, 1977. Invernizzi G., Carbone G., Meschini A., Parmiani G.: Multiple foreign non-H-2 determinants on the surface of a chemically induced murine sarcoma - J. Immunogenet.4, 47, 1977. Invernizzi G., Parmiani G.: Tumour-associated transplantation antigens of chemically induced sarcomata cross-reacting with allogeneic histocompatibility antigens - Nature (Lond.)254, 713, 1975. Jondal M., Svedmyr E., Klein E., Singh S.: Killer T cells in a Burkitt’s lymphoma biopsy - Nature (Lond.)266, 405, 1975. Kaneko Y., Natsuume-Sakai S., Migita S.: Cytotoxic T lymphocytes to murine plasmocytoma cells in allogeneic and syngeneic mice: H-2 antigens are essential in the induction and effector stages of CTL - J. Immunol.121, 427, 1978. Kearney R., Basten A., Nelson D. S.: Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogenicity of effector cells - Int. J. Cancer15, 438, 1975. Law L. W., Dubois G. C., Rogers M. J., Appella E., Pierotti M. A., Parmiani G.: Tumor rejection activity of antigens isolated from the membranes of a methylcholanthreneinduced sarcoma, C-l, bearing alien H-2 antigens - Transplant. Proc.12, 46, 1980. Lee S. K., Oliver R. T. D.: Autologous leukemia specific T cell-mediated lymphocytotoxicity in patients with acute myelogenous leukemia - J. exp. Med.147, 912, 1978. Lennox E.: Personal communication. Lennox E., Sikora K., Koch G.: The tumor specific transplantation antigens of methylcholanthrene induced murine sarcomas - In:Ferrone S., Herberman R. B., Reisfeld R. A., Gorini L. (Eds): Current trends in tumor immunology. Garland Publ. Inc., New York, 1979. Leonard E. J.: Cell surface antigen movement: induction in hepatoma cells by antitumor antibody - J. Immunol.110, 1167, 1973. Livingston P. O., Shiku H., Bean M. A., Pinsky C. M., Oettgen H. F., Old L. J.: Cellmediated cytotoxicity for cultured autologous melanoma cells - Int. J. Cancer24, 34, 1979. Malley A., Burger D. R., Vandenbark A. A., Frikke H., Finke P., Begley D., Acott K., Black J., Vetto R. M.: Association of melanoma tumor antigen activity with β2-microglobulin - Cancer Res.39, 619, 1979. Martin W. J.: Personal communication. Martin W. J., Esber E., Cotton W. G., Rice J. M.: Derepression of alloantigens in malignancy. Evidence for tumor susceptibility alloantigens and for possible self-reactivity of lymphoid cells active in the microcytotoxicity assay - Brit. J. Cancer28 (Suppl. 1), 48, 1973. Martin W. J., Gipson T. G., Conliffe M. D., Friedman R. J., Dove L., Rice J. M.: Common tumor-associated transplantation alloantigen detected on a proportion of lung tumors induced transplacentally in several strains of mice - Transplantation24, 294, 1977. Martin W. J., Gipson T. G., Rice J. M.: H-2a associated alloantigen expressed by several transplacentally induced lung tumors of C3Hf mice - Nature (Lond.)265, 738, 1977. McCabe R. P., Ferrone S., Pellegrino M. A., Kern D. H., Holmes E. C., Reisfeld R. A.: Purification and immunologic evaluation of human melanoma-associated antigens - J. nat. Cancer Inst.60, 773, 1978. Meruelo D., Deak B., McDevitt H. O.: Genetic control of cell-mediated responsiveness to an AKR tumor-associated antigen. Mapping of the locus involved to the I region of the H-2 complex - J. exp. Med.146, 1367, 1977. Meschini A., Invernizzi G., Parmiani G.: Expression of alien H-2 specificities on a chemically induced BALB/c flbrosarcoma - Int. J. Cancer20, 271, 1977. Meschini A., Parmiani G.: Anti-H-2 alloantibodies elicited by syngeneic immunizations with a chemically induced flbrosarcoma - Immunogenetics6, 117, 1978. Natori T., Law L. W., Appella E.: Biologic and biochemical properties of detergent-solubilized tumor-specific transplantation antigen from a simian virus 40-induced neoplasm - J. nat. Cancer Inst.59, 1331, 1977. Natori T., Law L. W., Appella E.: Immunochemical evidence of a tumor-specific surface antigen obtained by detergent solubilization of the membranes of a chemically induced sarcoma, Meth-A - Cancer Res.38, 359, 1978. Nelson D. S., Hopper K. E., Blanden R. V., Gardner I. D.: Failure of immunogenetic tumors to elicit cytolytic T cells in syngeneic hosts - Cancer Lett.5, 61, 1978. Old L. J., Stockert E.: Immunogenetics of cell surface antigens of mouse leukemia - Ann. Rev. Genet.11, 127, 1977. O’Toole C., Stejskal V., Perlmann P., Karlsson M.: Lymphoid cells mediating tumorspecific cytotoxicity to carcinoma of the urinary bladder - J. exp. Med.139, 457, 1974. Parmiani G.: Unpublished observations. Parmiani G.: Lack of identity between TSTA and alien antigens of methylcholanthrene-induced murine sarcomas - Transplant. Proc.12, 50, 1980. Parmiani G., Ballinari D.: Genetic control ofin vivo immunity to tumor-specific transplantation antigens of chemically induced murine fibrosarcomas - Int. J. Cancer23, 697, 1979. Parmiani G., Ballinari D., Sensi M. L.: Tumor-associated alien alloantigens of BALB/c tumors encoded by the MHC and by non-H-2 genes: a histogenetic study - J. Immunol.124, 662, 1980. Parmiani G., Carbone G., Invernizzi G., Meschini A., Della Porta G.: Expression of genetically inappropriate histocompatibility antigens on the cell surface of experimental tumors and their relationship to tumor-associated transplantation antigens - In:Spreafico F., Arnon R. (Eds): Tumor-associated antigens and their specific immune response. Academic Press, New York, 1979; p. 31. Parmiani G., Carbone G., Invernizzi G., Pierotti M. A., Sensi M. L., Rogers M. J., Appella E.: Alien histocompatibility antigens on tumor cells - Immunogenetics9, 1, 1979. Parmiani G., Invernizzi G.: Alien histocompatibility determinants on the cell surface of sarcomas induced by methylcholanthrene. I.In vivo studies - Int. J. Cancer16, 756, 1975. Parmiani G., Meschini A., Invernizzi G., Carbone G.: Tumor-associated transplantation antigen distinct from H-2k-like antigens on a BALB/c (H-2d) fibrosarcoma - J. nat. Cancer Inst.61, 1229, 1978. Pellegrino M. A., Ferrone S., Hayflick L.: Changes in HL-A antigens profiles on SV40-transformed human fibroblasts - Exp. Cell Res.97, 340, 1976. Phillips-Quagliata J. M., Walker M. C.: Genetic control of resistance to tumors - Amer. J. Path.93, 487, 1978. Prehn L. M., Outzen H. C.: Primary tumor immunity in nude mice - Int. J. Cancer19, 688, 1978. Robert F., Oth D., Dumont F.: Appearance of alien antigens in three ascitic sublines of a strain-specific solid polyoma-induced tumor line — (Submitted for publication). Rogers M. J., Appella E., Pierotti M. A., Invernizzi G., Parmiani G.: Biochemical characterization of alien H-2 antigens expressed on a methylcholanthrene-induced tumor - Proc. nat. Acad.Sci.(Wash.)76, 1415, 1979. Rogers M. J., Law L. W., Prat M., Oroszlan S., Appella E.: Separation of the tumor rejection antigen (TSTA) from the major viral structural proteins associated with the membrane of an R-MuLV-induced leukemia - Int. J. Cancer21, 246, 1978. Rollinghoff M., Warner N. L.: Specificity ofin vivo tumor rejection assessed by mixing immune spleen cells with target and unrelated tumor cells - Proc. Soc. exp. Biol. (N.Y.)144, 813, 1973. Rouse B. T. M., Rollinghoff M., Warner N. L.: Tumor-immunity to murine plasma cell tumors. III. Essential role of T lymphocytes in immune response - Europ. J. Immunol.3, 218, 1973. Russell J. H., Ginns L. C., Terres G., Eisen H. N.: Tumor antigens as inappropriately expressed normal alloantigens - J. Immunol.122, 912, 1979. Sato H., Boyse E. A., Aoki T., Iritani C., Old L. J.: Leukemia associated transplantation antigens related to murine leukemia virus. The X.1 system immune response controlled by a locus linked to H-2 - J. exp. Med.138, 593, 1973. Schirrmacher V., Garrido F., Garcia-Olivares E., Perez M., Torres M. D.: Expression of alien H-2-like antigens by a chemically induced murine tumor (MCG4) - J. Immunogenet.7, 51, 1980. Schirrmacher V., Garrido F., Hubsch D., Garcia-Olivares E., Koszinowski U.: Alien H-2-like molecules on a murine tumor (MCGA): target antigens for alloreactive cytolytic T lymphocytes (CTL) and restricting elements for virus specific CTL - Transplant. Proc.12, 32, 1980. Schrader J. W., Edelman G. M.: Participation of the H-2 antigens of tumor cells in their lysis by syngeneic T cells - J. exp. Med.143, 601, 1976. Sensi M. L., Carbone G., Parmiani G.: Unpublished observations. Snell G. D., Cherry M., Demant P.: H-2: its structure and similarity to HL-A - Transplant. Rev.15, 3, 1973. Thomson D. M. P., Gold P., Freedman S. O., Shuster J.: The isolation and characterization of tumor-specific antigens of rodent and human tumors - Cancer Res.36, 3518, 1976. Thomson D. M. P., Rauch J. E., Weatherhead J. C., Friedlander P., O’Connor R., Grosser N., Shuster J., Gold P.: Isolation of human tumour-specific antigens associated with β2-microglobulin - Brit. J. Cancer37, 153, 1978. Thomson D. M. P., Tataryn D. N., O’Connor R., Rauch J., Friedlander P., Gold P., Shuster J.: Evidence for the expression of human tumor-specific antigens associated with β2-microglobulin in human cancer and in some colon adenomas and benign breast lesions - Cancer Res.39, 604, 1979. Ting C. C., Herberman R. B.: Inverse relationship of polyoma tumor specific cell surface antigen to H-2 histocompatibility antigens - Nature (Lond.)232, 118, 1971. Ting C. C., Law L. W.: Studies of H-2 restriction in cell-mediated cytotoxicity and transplantation immunity to leukemia-associated antigens - J. Immunol.118, 4, 1977. Trinchieri G., Aden D. P., Knowles B. B.: Cell-mediated cytotoxicity to SV40-specific tumor-associated antigens - Nature (Lond.)261, 312, 1976. Vanky F., Klein E., Stjernsward J., Rodriguez L., Peterffy A., Steiner L., Nilsonne U.: Human tumor-lymphocyte interactionin vitro. III. T-lymphocytes in autologous tumor stimulation (ATS) - Int. J. Cancer22, 679, 1978. Vose B. M., Vanky F., Fopp M., Klein E.:In vitro generation of cytotoxicity against autologous human tumor biopsy cells - Int. J. Cancer21, 588, 1978. Vose B. M., Vanky F., Klein E.: Lymphocyte cytotoxicity against autologous tumour biopsy cells in humans - Int. J. Cancer20, 512, 1977. Williams R. M., Dorf M. E., Benacerraf B.: H-2 linked genetic control of resistance to histocompatibility tumors - Cancer Res.35, 1586, 1975. Wrathmell A., Gauci C. L., Alexander P.: Cross-reactivity of an allo-antigen present on normal cells with the tumour-specific transplantation type antigen of the acute myeloid leukemia (SAL) of rats - Brit. J. Cancer37, 187, 1976. Wybran J., Hellstrom I., Hellstrom K. E., Fudenberg H. H.: Cytotoxicity of human rosette-forming blood lymphocytes on cultivated human tumor cells - Int. J. Cancer13, 515, 1974. Yefenof E., Klein G.: Antibody-induced redistribution of normal and tumor associated surface antigens -Exp. Cell Res.88, 211, 1974. Zarling J. M., Bach F. H.: Sensitization of lymphocytes against pooled allogeneic cells. I. Generation of cytotoxicity against autologous human lymphoblastoid cell lines - J. exp. Med.147, 1334, 1978.